Modulation of Autoantigen Trafficking and TLR engagement by FcgRIIB and AP3B1
FcgRIIB 和 AP3B1 对自身抗原运输和 TLR 参与的调节
基本信息
- 批准号:8521057
- 负责人:
- 金额:$ 2.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-01 至 2015-08-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsAdaptor Protein Complex 3AffectAntibodiesAntigen-Antibody ComplexAttentionAutoantibodiesAutoantigensAutoimmune DiseasesAutoimmune ProcessAutoimmunityB Cell ProliferationB-LymphocytesBindingCellsClinicalComplexConfocal MicroscopyCytoskeletal ModelingDNADataDefectDendritic CellsDevelopmentDiseaseEffector CellEnvironmentExhibitsFlow CytometryGeneticGoalsHumanImmuneImmune Cell ActivationImmunoglobulin GIn VitroInterferon Type IInterferonsInterleukin-6LaboratoriesLigandsLupusMediatingModelingMolecularMonitorMusMyelogenousNucleic AcidsOutcomePathogenesisPatientsPatternPhagocytesPhase II Clinical TrialsPhosphorylationProcessProductionProliferatingPublic HealthRANTESRNAResistanceRibonucleasesRoleSignal TransductionSusceptibility GeneTLR7 geneTNF geneTestingTherapeutic Agentscytokinefunctional outcomesin vivo Modelinhibitor/antagonistmouse modelnovelpublic health relevanceresponsesensorsystemic autoimmune diseasetrafficking
项目摘要
DESCRIPTION (provided by applicant): Our lab is focused on understanding how pathogenic immune complexes (IC) formed from DNA and/or RNA and antibodies contribute to the pathogenesis of systemic lupus erythematous (SLE). We use in vitro and in vivo models to determine the molecular mechanisms that govern the activation of immune cells by DNA and/or RNA antibody complexes. This particular project is investigating how IC trafficking within immune cells affects the functional outcome. We have developed novel ICs that are also pH sensors. Using these ICs we can rapidly screen the effect of genetic factors and therapeutic agents on IC trafficking in B cells and phagocytes.
描述(由申请人提供):我们的实验室专注于了解由DNA和/或RNA和抗体形成的致病性免疫复合物(IC)如何促进系统性红斑狼疮(SLE)的发病机制。我们使用体外和体内模型来确定DNA和/或RNA抗体复合物激活免疫细胞的分子机制。这个特别的项目正在研究免疫细胞内的IC运输如何影响功能结果。我们开发了新型的IC,也是pH传感器。利用这些IC,我们可以快速筛选遗传因素和治疗剂对IC在B细胞和吞噬细胞中运输的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Krishna-sulayman Laroche Moody其他文献
Krishna-sulayman Laroche Moody的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Krishna-sulayman Laroche Moody', 18)}}的其他基金
Modulation of Autoantigen Trafficking and TLR engagement by FcgRIIB and AP3B1
FcgRIIB 和 AP3B1 对自身抗原运输和 TLR 参与的调节
- 批准号:
8397409 - 财政年份:2012
- 资助金额:
$ 2.96万 - 项目类别: